|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0425 - 0.0460|
|52 Week Range||0.0300 - 0.0600|
|Beta (5Y Monthly)||0.74|
|PE Ratio (TTM)||4.59|
|Earnings Date||Nov 13, 2023 - Nov 17, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for CVSI
CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced the launch of +PlusCBD™Reserve Collection Sleep Gummies as the brand continues to expand into the sleep aid market.
CV Sciences, Inc. (PNK:CVSI) Q2 2023 Earnings Call Transcript August 14, 2023 Operator: Hello, and welcome to the CV Sciences, Inc. Second Quarter 2023 Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It’s now my pleasure to turn the call over to your host, Brendan Hawkins. Please go ahead. Brendan Hawkins: […]
CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended June 30, 2023.